Bromopride structure
|
Common Name | Bromopride | ||
|---|---|---|---|---|
| CAS Number | 4093-35-0 | Molecular Weight | 344.247 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 435.8±45.0 °C at 760 mmHg | |
| Molecular Formula | C14H22BrN3O2 | Melting Point | 148-150ºC | |
| MSDS | N/A | Flash Point | 217.3±28.7 °C | |
Use of BromoprideBromopride is a dopamine antagonist with prokinetic properties, widely used as an antiemetic. |
| Name | 4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide |
|---|---|
| Synonym | More Synonyms |
| Description | Bromopride is a dopamine antagonist with prokinetic properties, widely used as an antiemetic. |
|---|---|
| Related Catalog |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 435.8±45.0 °C at 760 mmHg |
| Melting Point | 148-150ºC |
| Molecular Formula | C14H22BrN3O2 |
| Molecular Weight | 344.247 |
| Flash Point | 217.3±28.7 °C |
| Exact Mass | 343.089539 |
| PSA | 67.59000 |
| LogP | 2.67 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.565 |
| InChIKey | GIYAQDDTCWHPPL-UHFFFAOYSA-N |
| SMILES | CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Hazard Codes | Xn: Harmful; |
|---|---|
| Risk Phrases | 20/21/22 |
| Safety Phrases | 36 |
| WGK Germany | 3 |
| RTECS | BZ3280000 |
| HS Code | 2924299090 |
|
~%
Bromopride CAS#:4093-35-0 |
| Literature: Journal of the American Chemical Society, , vol. 133, # 15 p. 6061 - 6071 |
|
~%
Bromopride CAS#:4093-35-0 |
| Literature: Journal of the American Chemical Society, , vol. 133, # 15 p. 6061 - 6071 |
|
~%
Bromopride CAS#:4093-35-0 |
| Literature: Journal of the American Chemical Society, , vol. 133, # 15 p. 6061 - 6071 |
|
~%
Bromopride CAS#:4093-35-0 |
| Literature: Journal of the American Chemical Society, , vol. 133, # 15 p. 6061 - 6071 |
| HS Code | 2924299090 |
|---|---|
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Name: Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
Source: NCGC
External Id: SNCA-p-activity-luciferase
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify ago...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
Name: Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: lu...
Source: 824
External Id: CYP273
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify pos...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
|
|
Name: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity
Source: NCGC
External Id: HERG01
|
|
Name: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen
Source: NCGC
Target: N/A
External Id: SMAD3201
|
|
Name: uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay
Source: Burnham Center for Chemical Genomics
Target: cystic fibrosis transmembrane conductance regulator [Homo sapiens]
External Id: SBCCG-A764-CF-PAF-Primary-Assay
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify ant...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_ANT_FLUO8_1536_1X%INH PRUN
|
|
Name: qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green ...
Source: NCGC
Target: N/A
External Id: Ebola screen2_EMI141217_green
|
| 4-Amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide |
| Artomey |
| Valopride |
| 4-amino-5-bromo-N-(2-diethylaminoethyl)-2-anisamide |
| Viaben |
| 4-amino-5-bromo-N-(2-diethylaminoethyl)-2-methoxybenzamide |
| Viadil |
| Digesan |
| Plamet |
| 4-Amino-5-bromo-N-[2-(diethylamino)ethyl]-o-anisamide |
| Bromoprida [INN-Spanish] |
| Bromopridum [INN-Latin] |
| Emepride |
| Bromopride |
| Emoril |
| Bromoprida [Spanish] |